Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$33,454,503
+$7,481,119 QoQ
Shares Held
27,892
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#669
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $202,731,943 across 16 Drug Manufacturers - General names. LLY ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
348,943 | $88,621,053 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
27,892 | $33,454,503 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,656 | $28,739,795 | |
| 4 | AMGN |
Amgen Inc
|
47,244 | $17,107,996 | |
| 5 | ABBV |
AbbVie Inc.
|
51,835 | $13,043,758 | |
| 6 | AZN |
Astrazeneca PLC
|
32,878 | $6,234,325 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
106,605 | $6,142,579 | |
| 8 | PFE |
Pfizer Inc
|
185,530 | $4,467,561 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,454,503 | 27,892 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $25,973,384 | 28,239 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $31,300,057 | 29,125 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $21,290,752 | 27,904 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 | $29,391,398 | 37,704 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $32,615,185 | 39,490 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $31,523,848 | 40,834 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $35,486,325 | 40,055 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $15,586,116 | 17,215 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $13,720,101 | 17,636 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $10,199,024 | 18,988 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $9,016,609 | 19,226 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,848,480 | 19,942 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,725,076 | 21,116 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,996,970 | 21,639 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,060,756 | 21,777 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,023,223 | 24,525 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,888,649 | 24,939 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,799,123 | 25,099 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $6,033,391 | 26,287 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $4,837,703 | 25,895 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $4,598,357 | 27,235 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,275,113 | 28,882 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,209,759 | 31,732 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,639,074 | 33,442 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||